.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Merck
Teva
US Department of Justice
Chubb
Fish and Richardson
Queensland Health
US Army
Daiichi Sankyo
McKesson

Generated: September 25, 2017

DrugPatentWatch Database Preview

SYNTOCINON Drug Profile

« Back to Dashboard

What is the patent landscape for Syntocinon, and when can generic versions of Syntocinon launch?

Syntocinon is a drug marketed by Novartis and Rtrx and is included in two NDAs.

The generic ingredient in SYNTOCINON is oxytocin. There are eleven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the oxytocin profile page.

Summary for Tradename: SYNTOCINON

Patents:0
Applicants:2
NDAs:2
Bulk Api Vendors: see list25
Clinical Trials: see list46
Patent Applications: see list6,494
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SYNTOCINON at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis
SYNTOCINON
oxytocin
INJECTABLE;INJECTION018245-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Rtrx
SYNTOCINON
oxytocin
SOLUTION;NASAL012285-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Cantor Fitzgerald
Boehringer Ingelheim
Argus Health
Covington
Novartis
Mallinckrodt
Fish and Richardson
Julphar
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot